当前位置：首页 > 文献互助 > 互助详情

An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis复制

用户Jt1 4小时前 11 10 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2025-06-16 14:17:51 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: https://doi.org/10.1056/NEJMoa2308713复制

文献链接: http://www.nejm.org/doi/10.1056/NEJMoa2308713复制

其他信息:

出版社: Massachusetts Medical Society
作者: Robert Bissonnette; Andreas Pinter; Laura K. Ferris; Sascha Gerdes; Phoebe Rich; Ronald Vender; Megan Miller; Yaung-Kaung Shen; Arun Kannan; Shu Li; Cynthia DeKlotz; Kim Papp

上一篇：Oral Psoriasis Therapies

下一篇：Preclinical techniques for drug discovery in psoriasis

互助时间线

2025-06-09 14:18:45 [完结求助]

楼主确认了豆瓣酱123应助的文件是正确的, 求助状态变成 已完结

2025-06-09 14:17:51 [上传文件]

豆瓣酱123上传了文件(pdf 572.25 KB), 求助状态变成 待确认

2025-06-09 13:35:29 [发起求助]

最新发布的求助

Standardized HILIC-FLD N-Glycan Analysis for Assessing N-Glycosylation Heterogeneity and Glycosylation-Related Quality Attributes in Bevacizumab from Multiple Manufacturers 13分钟前
NAD(P)‐Dependent Glucose Dehydrogenases: Underestimated Multifunctional Biocatalysts 56分钟前
Cyclic Peptide Therapeutic Agents Discovery: Computational and Artificial Intelligence-Driven Strategies 1小时前
Lidocaine patch for treatment of acute localized pain in the emergency department: a systematic review and meta-analysis 2小时前
Oral iptacopan for paroxysmal nocturnal haemoglobinuria—First real‐world experience 2小时前
中华医学会肺癌临床诊疗指南(2024 版). 2小时前
A novel and robust 3-quinuclidinone reductase from Kaistia algarum for efficient synthesis of (R)-3-quinuclidinol without external cofactor 2小时前
supplement-Joint Associations of APOC3 and LDL-C-Lowering Variants With the Risk of Coronary Heart Disease 3小时前
Genetics of Psoriasis 4小时前
Preclinical techniques for drug discovery in psoriasis 4小时前
An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis 4小时前
Oral Psoriasis Therapies 4小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com